Empagliflozin 10 & 25 Zydus 10 mg, 25 mg Tablet
PDF Leaflet Revision Date: 01 August 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunct to diet and exercise for type 2 diabetes mellitus.
Dosage (summary)
Starting dose: 10 mg once daily; may increase to 25 mg if needed.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Increased risk of hypoglycaemia with insulin or sulphonylureas
- Diuretics may enhance dehydration risk
Contraindications
- Type 1 diabetes
- Ketoacidosis
- Severe renal impairment
- Pregnancy
- Lactation
Common side effects
- Genital infections
- Urinary tract infections
- Hypoglycaemia
Counselling Points
- Monitor for signs of ketoacidosis
- Assess hydration status
- Counsel on foot care
Serious warnings
- Risk of ketoacidosis
- Volume depletion
- Lower limb amputations
Important Disclaimer
The Empagliflozin 10 & 25 Zydus 10 mg, 25 mg Tablet professional information leaflet below is the property of Zydus Healthcare Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
